PharmaVoice ١٠ ديسمبر ٢٠٢٥ Another genetic testing company? Why a different approach could boost drug predictions and R&D.
PharmaVoice ٤ ديسمبر ٢٠٢٥ BeOne brought Brukinsa to the blood cancer mountaintop. Can it hit those heights again?
PharmaVoice ٣ ديسمبر ٢٠٢٥ Hemophilia gene therapies are struggling on the market, even as innovation soars
PharmaVoice ١ ديسمبر ٢٠٢٥ Redefining CAR-T speed and strength with DAR-T™: A conversation with Nicholas Kirian
PharmaVoice ٢٤ نوفمبر ٢٠٢٥ Eli Lilly becomes first drugmaker to hit $1 trillion in market value #Eli Lilly #drugmaking peers